Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma. Chirico A, Henderson Berg MH, Roberge D, Pehr K, et al. Br J Dermatol 2020 Aug 15. doi: 10.1111/bjd.19490.

Read + Share

Amedeo Smart

Independent Medical Education

Chirico A, Henderson Berg MH, Roberge D, Pehr K, et al. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphoma. Br J Dermatol 2020 Aug 15. doi: 10.1111/bjd.19490.
PMID: 32798319